ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 252

Correlations between Clinical and Ultrasound Scores of Peripheral Enthesitis and Disease Activity Scores in a Cohort of Spondyloarthritis

Assia Haddouche1, Sabrina Haid2, Siham Bencheikh3, Samy Slimani4, Amina Abdessemed5, Nadjia Brahimi6, Aïcha Ladjouz Rezig6 and Fella Hanni6, 1of Medicine, Department of Medicine, University of Algiers 1, Algiers, Algeria, 2medicine, Department of Medicine, University of Algiers 1, Algiers, Algeria, 3EPH HADJOUT, Algiers, Algeria, 4Department of Medicine, University of Batna, Batna, Algeria, 5Medicine, Department of Medicine, University of Algiers 1, Algiers, Algeria, 6Department of Medicine, University of Algiers 1, Algiers, Algeria

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Enthesitis, spondylarthropathy and ultrasound

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 5, 2017

Title: Imaging of Rheumatic Diseases Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: To look correlations between clinical and ultrasound (US) scores of peripheral enthesitis (PE) and disease activity scores of SpA

Methods: A prospective study of 208 SpAs meeting SpA ASAS criteria. In the same consultation, 30 enthesitic sites per patient were examined clinically and 34 sites per patient were examined with US according to the US OMERACT 2014 definition of enthesitis. PE was assessed by the following clinical scores: Enthesitis Peripheral Score (PES= Sum of symptomatic peripheral entheses sites on clinical examination), Visual Analog Scale of peripheral enthesitis (VAS), Spondyloarthritis Research Consortium of Canada score (SPARCC) as well as the following US enthesitis scores: Acute Enthesitis scorev Correlations between clinical scores and ultrasound scores and disease activity scores were calculated using SPSS software.

Results: A total of 208 patients were included, mainly men (63.5%). The mean age was 40.2 ± 11.7 years. The mean duration of the SpA was 11.8 ± 8.7 years. Axial radiographic SpA was the most frequent phenotype (69.2%). On examination 64.4% of SpA were NSAIDs and 88.9% had active disease (ASDAS-vs and / or ASDAS-crp> 1.3). Tables (1, 2) summarize the results of correlations between clinical scores and US scores and disease activity scores. A weak correlation was found between: the acute enthesitis score and two clinical scores (peripheral enthesitis score, mean score of enthesitic VAS); the global enthesitis score and all clinical enthesitis scores and finally between the SES score and two clinical enthesitic scores (peripheral enthesitis score, mean score of enthesitic VAS).

A moderate correlation was observed between disease activity scores and all US scores of peripheral enthesitis except for the chronic enthesitis score for which the correlation was weak.

Table 1

Scores

PES

VASm

Enthestis

SPARCC

Acute Enthesitis

r: 0,15

p: 0,03

r: 0,15

p: 0,03

r: 0,13

p: 0,06

Chronic Enthesitis

r: 0,10

p: 0,15

r: 0,09

p: 0,17

r: 0,09

p: 0,26

Global  Enthesitis

r: 0,16

p: 0,02

r: 0,16

p: 0,03

r: 0,14

p: 0,04

Doppler  Enthesitis

r: 0,06

p: 0,36

r: 0,07

p: 0,32

r: 0,06

p: 0,42

MASEI

r: 0,13

p: 0,06

r: 0,13

p: 0,23

r: 0,13

p: 0,07

SES

r: 0,13

p : 0,06

r: 0,13

p : 0,04

r: 0,13

p:0,05

Table 2

ASDAS-vs

ASDAS-crp

PES

r: 0,41*

p <0,0001

r: 0,39*

p <0,0001

VASm Enthestis

r: 0,43*

p <0,0001

r: 0,40*

p <0,0001

SPARCC

r: 0,39*

p <0,0001

r: 0,38*

p<0,0001

Acute  Enthesitis

r: 0,33*

P <0,0001

r: 0,46*

p<0,0001

Chronic Enthesitis

r: 0,18

p: 0,006

r: 0,23

p: 0,002

Global  Enthesitis

r: 0,35*

p <0,0001

r: 0,46*

p<0,0001

Doppler  Enthesitis

r: 0,29*

p <0,0001

r: 0,34*

p<0,0001

MASEI

r: 0,38*

p <0,0001

r:0,48*

p<0,0001

SES

r: 0,32*

p <0,0001

r: 0,42*

p<0,0001

Conclusion: All clinical and US scores, except for the chronic enthesitis score, would be of interest in assessing disease activity of SpA. US scores are weakly or even uncorrelated to the peripheral enthesitis clinical scores


Disclosure: A. Haddouche, None; S. Haid, None; S. Bencheikh, None; S. Slimani, None; A. Abdessemed, None; N. Brahimi, None; A. Ladjouz Rezig, None; F. Hanni, None.

To cite this abstract in AMA style:

Haddouche A, Haid S, Bencheikh S, Slimani S, Abdessemed A, Brahimi N, Ladjouz Rezig A, Hanni F. Correlations between Clinical and Ultrasound Scores of Peripheral Enthesitis and Disease Activity Scores in a Cohort of Spondyloarthritis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/correlations-between-clinical-and-ultrasound-scores-of-peripheral-enthesitis-and-disease-activity-scores-in-a-cohort-of-spondyloarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/correlations-between-clinical-and-ultrasound-scores-of-peripheral-enthesitis-and-disease-activity-scores-in-a-cohort-of-spondyloarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology